| UniProt ID | TCHP_HUMAN | |
|---|---|---|
| UniProt AC | Q9BT92 | |
| Protein Name | Trichoplein keratin filament-binding protein | |
| Gene Name | TCHP {ECO:0000312|EMBL:AAH04285.1} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 498 | |
| Subcellular Localization | Cytoplasm, cytoskeleton . Cytoplasm . Cell membrane . Mitochondrion . Cell junction, desmosome . | |
| Protein Description | Tumor suppressor which has the ability to inhibit cell growth and be pro-apoptotic during cell stress. Inhibits cell growth in bladder and prostate cancer cells by a down-regulation of HSPB1 by inhibiting its phosphorylation. May act as a 'capping' or 'branching' protein for keratin filaments in the cell periphery. May regulate K8/K18 filament and desmosome organization mainly at the apical or peripheral regions of simple epithelial cells. [PubMed: 15731013] | |
| Protein Sequence | MALPTLPSYWCSQQRLNQQLARQREQEARLRQQWEQNSRYFRMSDICSSKQAEWSSKTSYQRSMHAYQREKMKEEKRRSLEARREKLRQLMQEEQDLLARELEELRLSMNLQERRIREQHGKLKSAKEEQRKLIAEQLLYEHWKKNNPKLREMELDLHQKHVVNSWEMQKEEKKQQEATAEQENKRYENEYERARREALERMKAEEERRQLEDKLQAEALLQQMEELKLKEVEATKLKKEQENLLKQRWELERLEEERKQMEAFRQKAELGRFLRHQYNAQLSRRTQQIQEELEADRRILQALLEKEDESQRLHLARREQVMADVAWMKQAIEEQLQLERAREAELQMLLREEAKEMWEKREAEWARERSARDRLMSEVLTGRQQQIQEKIEQNRRAQEESLKHREQLIRNLEEVRELARREKEESEKLKSARKQELEAQVAERRLQAWEADQQEEEEEEEARRVEQLSDALLQQEAETMAEQGYRPKPYGHPKIAWN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 50 | Ubiquitination | MSDICSSKQAEWSSK HHHHCCCCCCCCCCC | 36.91 | PubMed | |
| 57 | Ubiquitination | KQAEWSSKTSYQRSM CCCCCCCCHHHHHHH | 35.65 | PubMed | |
| 71 | Acetylation | MHAYQREKMKEEKRR HHHHHHHHHHHHHHH | 58.42 | 12649993 | |
| 122 | Ubiquitination | RIREQHGKLKSAKEE HHHHHHCCHHCHHHH | 51.09 | - | |
| 132 | Ubiquitination | SAKEEQRKLIAEQLL CHHHHHHHHHHHHHH | 43.89 | - | |
| 140 | Phosphorylation | LIAEQLLYEHWKKNN HHHHHHHHHHHHHHC | 17.84 | 28796482 | |
| 144 | Ubiquitination | QLLYEHWKKNNPKLR HHHHHHHHHHCHHHH | 47.75 | - | |
| 170 | Ubiquitination | VNSWEMQKEEKKQQE HHHHHHHHHHHHHHH | 67.54 | - | |
| 214 | Ubiquitination | ERRQLEDKLQAEALL HHHHHHHHHHHHHHH | 32.88 | - | |
| 228 | Ubiquitination | LQQMEELKLKEVEAT HHHHHHHCCHHHHHH | 61.87 | - | |
| 246 | Ubiquitination | KEQENLLKQRWELER HHHHHHHHHHHHHHH | 40.77 | - | |
| 259 | Ubiquitination | ERLEEERKQMEAFRQ HHHHHHHHHHHHHHH | 58.22 | - | |
| 278 | Phosphorylation | GRFLRHQYNAQLSRR HHHHHHHHHHHHHHH | 13.31 | 22817900 | |
| 283 | Phosphorylation | HQYNAQLSRRTQQIQ HHHHHHHHHHHHHHH | 13.98 | - | |
| 306 | Ubiquitination | ILQALLEKEDESQRL HHHHHHHCCCHHHHH | 71.13 | - | |
| 390 | Ubiquitination | RQQQIQEKIEQNRRA HHHHHHHHHHHHHHH | 34.86 | - | |
| 469 | Phosphorylation | ARRVEQLSDALLQQE HHHHHHHHHHHHHHH | 22.11 | 27050516 | |
| 488 | Ubiquitination | AEQGYRPKPYGHPKI HHCCCCCCCCCCCCC | 41.70 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCHP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCHP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LZTS2_HUMAN | LZTS2 | physical | 25416956 | |
| K1C40_HUMAN | KRT40 | physical | 25416956 | |
| DYDC1_HUMAN | DYDC1 | physical | 25416956 | |
| MIPO1_HUMAN | MIPOL1 | physical | 25416956 | |
| CC172_HUMAN | CCDC172 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...